Published in Medical Devices and Surgical Technology Week, October 8th, 2006
According to recent research from Australia, "Previous studies have investigated the role of volatile anaesthetic agents in myocardial protection during (CABG) surgery, and some have identified beneficial effects. However, these studies have been too small to identify a significant effect on myocardial infarction (MI) or mortality."
J.A. Symons and colleagues, Monash University, wrote, "We undertook a systematic overview and meta-analysis of all randomized trials comparing volatile with nonvolatile anaesthesia in CABG surgery. We...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.